Literature DB >> 25288144

Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand.

Pacharaporn Phueanpinit1, Narumol Jarernsiripornkul, Juraporn Pongwecharak, Janet Krska.   

Abstract

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used for patients to manage pain and inflammation, especially in older adults. Failure to cope with some adverse drug reactions (ADRs) of NSAIDs could lead to more serious symptoms, therefore, providing useful information about medicine is an important step in protecting patients from developing serious ADRs. The pharmacy service should be a frequent source of medicine information for patients, however in Thailand, little is known about pharmacists' provision of safety information to patients for management and prevention of these ADRs.
OBJECTIVE: Aims of this study were to determine Thai hospital pharmacists' roles in providing drug safety information and to assess their attitudes towards the importance of giving drug safety education to patients.
SETTING: All government hospitals in north-eastern Thailand.
METHODS: This study was a cross-sectional survey. A total of 761 pharmacists in 287 hospitals in north-eastern Thailand were selected by stratified random sampling. Self-administered questionnaires were sent by post, with two reminders. MAIN OUTCOME MEASURES: Proportion of hospital pharmacists providing ADR information on NSAIDs to patients, factors affecting this provision, and pharmacist attitudes towards drug safety education for patients.
RESULTS: The response rate was 54.8% (N = 417), the majority of respondents worked in community hospitals (57.2%). A total of 347 pharmacists (83.6%) had informed patients about ADRs, although less than half had informed patients about ADR monitoring and management (36.6% and 44.1% respectively). The proportion of time spent in direct patient contact, type of hospital, and other routine work were associated with the frequency of drug safety information provision. Pharmacists had moderately good attitudinal scores towards drug safety education (62.2 ± 5.4), with significantly higher scores found in those who provided most ADR information to patients (60.3 ± 5.2 vs. 62.6 ± 5.4, P = 0.002). The majority (82.2%) agreed that patient information leaflets should be provided.
CONCLUSIONS: Thai hospital pharmacists' provision of ADR information for NSAIDs may occur less frequently than is desirable. However, their positive attitude towards provision of ADR information suggests that drug safety education by pharmacists should be routinely provided to patients, particularly patients at high risk of NSAID use.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25288144     DOI: 10.1007/s11096-014-0018-7

Source DB:  PubMed          Journal:  Int J Clin Pharm


  24 in total

Review 1.  Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale.

Authors:  Muhammad Amer; Valeriani R Bead; Joan Bathon; Roger S Blumenthal; David N Edwards
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

2.  Patient counseling practices in U.S. pharmacies: effects of having pharmacists hand the medication to the patient and state regulations on pharmacist counseling.

Authors:  Carole L Kimberlin; Allison Newland Jamison; Stephan Linden; Almut G Winterstein
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Jul-Aug

3.  Patient perspective of medication information desired and barriers to asking pharmacists questions.

Authors:  Janelle L Krueger; Carol J Hermansen-Kobulnicky
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Jul-Aug

4.  Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA).

Authors:  Graziano Onder; Claudio Pedone; Francesco Landi; Matteo Cesari; Cecilia Della Vedova; Roberto Bernabei; Giovanni Gambassi
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

Review 5.  Controversies and advances in non-steroidal anti-inflammatory drug (NSAID) analgesia in chronic pain management.

Authors:  Seema Shah; Vivek Mehta
Journal:  Postgrad Med J       Date:  2011-11-03       Impact factor: 2.401

6.  Patients' knowledge of adverse reactions to current medications.

Authors:  Garret Cullen; Emer Kelly; Frank E Murray
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

7.  Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Authors:  Derjung M Tarn; Debora A Paterniti; Bradley R Williams; Camille S Cipri; Neil S Wenger
Journal:  J Am Geriatr Soc       Date:  2009-01-17       Impact factor: 5.562

8.  Pharmacist intervention reduces gastropathy risk in patients using NSAIDs.

Authors:  Victoria Ibañez-Cuevas; Eduardo Lopez-Briz; M Teresa Guardiola-Chorro
Journal:  Pharm World Sci       Date:  2008-10-19

9.  A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions.

Authors:  Nataporn Chaipichit; Janet Krska; Thongchai Pratipanawatr; Verawan Uchaipichat; Narumol Jarernsiripornkul
Journal:  Eur J Clin Pharmacol       Date:  2014-02-16       Impact factor: 2.953

10.  What do patients in rheumatologic care know about the risks of NSAIDs?

Authors:  Lykke Midtbøll Ornbjerg; Henning B Andersen; Peter Kryger; Bryan Cleal; Merete Lund Hetland
Journal:  J Clin Rheumatol       Date:  2008-04       Impact factor: 3.517

View more
  9 in total

1.  Knowledge, Beliefs and Behaviours Regarding the Adverse Effects of Medicines in an Omani Population: Cross-sectional survey.

Authors:  Jimmy Jose; Beena Jimmy; Moza N S Al-Mamari; Thuraiya S N Al-Hadrami; Halima M Al-Zadjali
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

2.  Public confidence in ADR identification and their views on ADRreporting: mixed methods study.

Authors:  Narumol Jarernsiripornkul; Arunrot Patsuree; Janet Krska
Journal:  Eur J Clin Pharmacol       Date:  2016-11-11       Impact factor: 2.953

3.  Survey of patients' experiences and their certainty of suspected adverse drug reactions.

Authors:  Jarernsiripornkul Narumol; Patsuree Arunrot; Janet Krska
Journal:  Int J Clin Pharm       Date:  2015-01-10

4.  Exploring Healthcare Professionals' Practices and Attitudes towards Monitoring and Reporting of Severe Adverse Drug Reactions.

Authors:  Warisara Srisuriyachanchai; Anthony R Cox; Narumol Jarernsiripornkul
Journal:  Healthcare (Basel)       Date:  2022-06-10

5.  Medicine information leaflets for non-steroidal anti-inflammatory drugs in Thailand.

Authors:  Pacharaporn Phueanpinit; Juraporn Pongwecharak; Janet Krska; Narumol Jarernsiripornkul
Journal:  Int J Clin Pharm       Date:  2015-11-18

6.  Experiences and Views of Medicine Information Among the General Public in Thailand.

Authors:  Kamonphat Wongtaweepkij; Janet Krska; Juraporn Pongwecharak; Narumol Jarernsiripornkul
Journal:  Patient Prefer Adherence       Date:  2020-06-30       Impact factor: 2.711

7.  Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients' knowledge.

Authors:  Narumol Jarernsiripornkul; Pacharaporn Phueanpinit; Juraporn Pongwecharak; Janet Krska
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

8.  Comparative evaluation of drug information leaflets for non-steroidal anti-inflammatory drugs in Palestine: local versus imported products.

Authors:  Dina A Arandy; Maysa W Abu-Hashia; Bahaa M Al-Hroub; Sandra A Qatmosh; Amer A Koni; Baraa G Qeeno; Samah W Al-Jabi; Sa'ed H Zyoud
Journal:  BMC Health Serv Res       Date:  2019-11-27       Impact factor: 2.655

9.  Evaluation of Patient's Knowledge of Atorvastatin Information in Patient Information Leaflets: A Pre-Post Intervention Study in Thailand.

Authors:  Supawinee Pongpunna; Thongchai Pratipanawatr; Kamonphat Wongtaweepkij; Narumol Jarernsiripornkul
Journal:  Patient Prefer Adherence       Date:  2021-10-28       Impact factor: 2.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.